Navigation Links
Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobel's Frank Sherman Delivers Keynote Address
Date:6/27/2012

HOUSTON, June 27, 2012 /PRNewswire/ --  Leading events organizer UBM Live today announced that the third annual Specialty Chemical Forum is underway at the Renaissance Houston Greenway Plaza Hotel in Houston, Texas. The Specialty Chemical Forum, taking place over the next two days, is part of the Informex brand's annual line-up of events and is the only North American event of its kind dedicated to the specialty chemical market. In addition to daily speaker panel presentations, table-top exhibitions are on display throughout the Forum to highlight a range of industry-leading suppliers with technologies and solutions specific to this market.

Frank Sherman, president of AkzoNobel Inc, opened the Forum today with a keynote address titled 'Examining domestic trends in the US specialty chemical market in order to take advantage of key growth opportunities'. During his keynote address, Mr. Sherman noted that, "Sustainable megaforces are often seen as a threat, but now is the time for the chemical industry to look to these as an opportunity to energize their businesses for the future. Changing global population and wealth structures and limited availability of resources, such as water and fuel, present a challenge to find new ways to approach business. Overcoming these challenges will undoubtedly help to pave the way for tomorrow's innovations."

The Specialty Chemical Forum was expanded into a two-day program for 2012 based on feedback from attendees, exhibitors and speakers from the past two years of the event. This year's expanded agenda features direct access to 24 in-depth presentations and panel discussions with built-in networking sessions that cover market trends, regulations, strategic sourcing, and the latest technical innovations. These presentations have been grouped in two different learning tracks, one with a focus on business development and the other on technical innovations. The Spec
'/>"/>

SOURCE Informex
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Agility Clinical, Inc., a Specialty Contract Research Organization is Formed
2. Elsevier and Federation of Biochemical Societies Launch New Journal: FEBS Open Bio
3. Bio architecture lab technology converts seaweed to renewable fuels and chemicals
4. AMPAC Fine Chemicals Continues to Invest in Quality Systems
5. 2 for 1: Simultaneous size and electrochemical measurement of nanomaterials
6. CELEXION Awarded Patent on Biosynthesis of Renewable Chemicals
7. Defending against chemical acts of terrorism
8. In chemical reactions, water adds speed without heat
9. Study shows availability of hydrogen controls chemical structure of graphene oxide
10. New twist on old chemical process could boost energy efficiency
11. Defending against chemical acts of terrorism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Asymmetrex, LLC ... progress in evaluating the full range of capabilities of its unique cache of ... cells perform the day-to-day renewal and repair of normal tissues and organs. This ...
(Date:7/28/2015)... July 28, 2015  PDL BioPharma, Inc. (PDL, or ... the Company will release its second quarter 2015 financial ... Wednesday, August 5, 2015, after market close. PDL,s management ... at 4:30 p.m. Eastern Time to discuss the financial ... be available via the webcast link on the PDL ...
(Date:7/28/2015)... 21, 2015 Research and Markets ( ... "Biomedical Refrigerators and Freezers Market - Global ... 2014 - 2022" report to their offering. ... freezers market has been segmented based on applications: ... and others. The others segment includes applications of ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
Breaking Biology Technology:Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2
... , ... Specialist Segmentation Module explores how oncologists use the Internet and other technologies for professional ... ... than the overall population of U.S. physicians to visit pharmaceutical, biotech, and device corporate ...
... , , , PHILADELPHIA, ... technologies for biomedical research, molecular diagnostics and personalized medicine, today ... have joined the company,s advisory team. Dr. Lee is ... at Brigham and Women,s Hospital, Harvard Medical School and the ...
... HOERSHOLM, Denmark and SAN DIEGO, California, September 16 /PRNewswire/,-- , ... Leading RNA Industry Expert,Art Levin Ph.D. as President of US ... - Utilizing its Proprietary RNA Chemistry - Locked Nucleic Acid ... Relationships,With New Partners, Increase Visibility With Capital Markets and Attract,Leading ...
Cached Biology Technology:Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 2Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 3Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 4BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 2BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 3BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 4New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations 2New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations 3New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations 4
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, featuring FPC,s touch ... 2015 that relate to sales of FPC1025 for this smartphone model ... for 2015. Jörgen Lantto, CEO of FPC, comments: " ... China and we are proud that ZTE ... Axon , its first smartphone ...
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
(Date:7/8/2015)... 8, 2015 Summary Pancreatic cancer is ... most fatal, with a mortality rate of 10.9 deaths ... pancreatic cancer patients has highlighted a significant need for ... being met by the current market. A highly ... with varying molecule types and mechanisms of action, which ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... people are injured or die each year in hospitals ... hospital, depending on its size, about US$5.6 million every ... the personal costs of injuries to patients. , Nationally, ... hospital admission are enormous: between $1.6 billion and $5.6 ...
... designated a group of 13 tropical ... African Sleeping Sickness (African trypanosomiasis), Chagas ... (elephantiasis), Onchocerciasis (river blindness), Drancunculiasis (guinea ... Trachoma). , These diseases have much ...
... production of a protein called vasostatin may prove a promising ... of print in Gut. , Pancreatic cancer is the fifth ... is extremely difficult to treat. Only 3% of affected patients ... that has remained static for the past three decades. , ...
Cached Biology News:Is it Possible to Change Prescribing Habits? 2Is it Possible to Change Prescribing Habits? 3A New Era of Hope for the World's Most Neglected Diseases 2A New Era of Hope for the World's Most Neglected Diseases 3Gene therapy potential for treatment of pancreatic cancer 2
... , Customer Peptide Synthesis , 20 Amino Acid length ... 20 mg will return to customer for future usage conjugation ... , Maintenance 102 days/each , ... x5 /each , Test bleed (app. 5 ml) ...
Request Info...
... This Kit Contains the following: , Coated Capture ... sealers , Wash/Sample Diluent: 300 mL of 2X ... vial 10 microg lyophilized peptide , Lyophilized Standard ... of 50X concentrate , Secondary Antibody-HRP: 30 microL ...
...
Biology Products: